Aura Biosciences Overview
Aura Biosciences (AURA) has a P/E ratio of -3.93, below the sector sector average of 35.43.
Get informed when a big investor buys or sells
+ Follow-3.93
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for AURA is -3.93. That is below the sector sector average of 35.43. Investors often review this figure alongside Aura Biosciences's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, AURA currently prints -3.93 for P/E ratio, while the sector average sits near 35.43. That is roughly 111.1% below the sector mean. Large gaps often invite a closer look at Aura Biosciences's growth, margins, and balance sheet.
A P/E ratio of -3.93 for Aura Biosciences is not 'good' or 'bad' on its own. Compare it with the peer average (35.43) and with AURA's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting AURA's P/E ratio (-3.93), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
